How is pharmaceutical marketing evolving toward precision-driven campaigns and digital innovation for 2026? Explore how strategies are emphasizing a shift toward omnichannel engagement as the standard for creating personalized, seamless experiences for both patients and healthcare providers. Success in this new landscape will require leveraging artificial intelligence for audience segmentation while maintaining a strong commitment to data privacy and patient-centricity. Responsory’s insight: Omnichannel is no longer a differentiator. It’s table stakes. And brands that treat AI segmentation and patient empowerment as add-ons rather than foundational pillars will lose ground to competitors who’ve redesigned their entire go-to-market around precision and trust.

View article